clinical
Curodont maker vVARDIS cuts U.S. IPO target to US$200 million
Curodont maker vVARDIS cuts U.S. IPO target to US$200 million Oral Health Group
By Oral Health Group ·
Curodont maker vVARDIS cuts U.S. IPO target to US$200 million Oral Health Group